S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
NASDAQ:FATE

Fate Therapeutics - FATE Short Interest Ratio & Short Volume

$33.82
+1.17 (+3.58%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$32.85
$35.19
50-Day Range
$17.78
$34.14
52-Week Range
$17.10
$91.90
Volume
1.42 million shs
Average Volume
1.34 million shs
Market Capitalization
$3.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.42

Fate Therapeutics Short Interest Data

Current Short Volume
21,100,000 shares
Previous Short Volume
21,220,000 shares
Change Vs. Previous Month
-0.57%
Dollar Volume Sold Short
$644.18 million
Short Interest Ratio / Days to Cover
13.0
Last Record Date
July, 31 2022
Outstanding Shares
97,000,000 shares
Float Size
90,510,000 shares
Short Percent of Float
23.31%
Today's Trading Volume
1,423,844 shares
Average Trading Volume
1,341,828 shares
Today's Volume Vs. Average
6.11%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Fate Therapeutics ?

Sign up to receive the latest short interest report for Fate Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FATE Short Interest Over Time

FATE Days to Cover Over Time

FATE Percentage of Float Shorted Over Time


Fate Therapeutics (NASDAQ:FATE) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202221,100,000 shares $644.18 million -0.6%23.3%13 $30.53
7/15/202221,220,000 shares $672.67 million -3.6%23.4%12.9 $31.70
6/30/202222,010,000 shares $545.41 million +6.8%24.4%13.6 $24.78
6/15/202220,600,000 shares $399.23 million +0.6%36.4%13.1 $19.38
5/31/202220,470,000 shares $472.86 million +14.4%22.6%14.3 $23.10
5/15/202217,900,000 shares $433.54 million +8.2%19.8%12.8 $24.22
4/30/202216,550,000 shares $472.67 million +3.4%18.3%12.9 $28.56
4/15/202216,000,000 shares $604.32 million +3.8%17.8%12.2 $37.77
3/31/202215,420,000 shares $597.83 million -1.7%17.1%11.3 $38.77
3/15/202215,690,000 shares $491.25 million +2.0%17.4%11.5 $31.31
2/28/202215,390,000 shares $531.72 million +11.9%17.1%10.8 $34.55
2/15/202213,760,000 shares $521.23 million +9.6%15.4%10 $37.88
1/31/202212,550,000 shares $520.95 million +7.5%14.0%9.8 $41.51
1/15/202211,670,000 shares $505.08 million +1.6%13.0%9.5 $43.28
12/31/202111,490,000 shares $672.28 million +6.3%12.8%10.2 $58.51
12/15/202110,810,000 shares $590.98 million -0.4%12.0%9.8 $54.67
11/30/202110,850,000 shares $596.86 million +7.0%12.1%11.7 $55.01
11/15/202110,140,000 shares $544.82 million -1.8%11.3%10.9 $53.73
10/29/202110,330,000 shares $555.75 million -3.9%11.6%9.7 $53.80
10/15/202110,750,000 shares $658.33 million -5.7%12.1%10.2 $61.24
9/30/202111,400,000 shares $675.68 million -3.4%12.8%11.4 $59.27
9/15/202111,800,000 shares $784.70 million -1.2%13.2%12 $66.50
8/31/202111,940,000 shares $874.61 million -3.1%13.4%11.6 $73.25
8/13/202112,320,000 shares $1.07 billion +0.8%13.8%12.2 $86.71
7/30/202112,220,000 shares $1.01 billion +5.0%13.7%13 $82.80
7/15/202111,640,000 shares $892.79 million -1.7%13.2%12 $76.70
6/30/202111,840,000 shares $1.03 billion +0.4%13.4%12.1 $86.79
6/15/202111,790,000 shares $1.02 billion -3.1%13.4%11.4 $86.79
5/28/202112,170,000 shares $932.22 million -6.5%13.8%12 $76.60
5/14/202113,020,000 shares $931.06 million +6.5%N/A12.9 $71.51
4/30/202112,230,000 shares $1.05 billion +1.3%N/A12.2 $85.87
4/15/202112,070,000 shares $1.02 billion +0.1%N/A12.3 $84.73
3/31/202112,060,000 shares $893.53 million +4.3%N/A11.6 $74.09
3/15/202111,560,000 shares $1.09 billion +12.2%N/A11.2 $93.99
2/26/202110,300,000 shares $888.58 million +7.0%N/A8.2 $86.27
2/12/20219,630,000 shares $987.08 million -4.5%N/A8 $102.50
1/29/202110,080,000 shares $916.37 million -0.8%N/A8.7 $90.91
1/15/202110,160,000 shares $1.19 billion -8.0%N/A8.9 $117.40
12/31/202011,040,000 shares $1.03 billion -15.6%N/A9.7 $93.62
12/15/202013,080,000 shares $1.26 billion -9.2%N/A12.2 $96.38
11/30/202014,400,000 shares $834.05 million +0.9%N/A13.2 $57.92
11/15/202014,270,000 shares $720.78 million -0.6%N/A16 $50.51
10/30/202014,350,000 shares $654.79 million -3.6%N/A16.7 $45.63
10/15/202014,880,000 shares $698.76 million +7.1%N/A17.4 $46.96
9/30/202013,900,000 shares $555.58 million +7.6%N/A17.2 $39.97
9/15/202012,920,000 shares $485.28 million +1.9%N/A16.2 $37.56
8/31/202012,680,000 shares $461.55 million +2.6%N/A16.2 $36.40
8/14/202012,360,000 shares $425.31 million +1.4%N/A13.6 $34.41
7/31/202012,190,000 shares $381.18 million -0.6%N/A12.1 $31.27
7/15/202012,260,000 shares $427.51 million -1.0%N/A12 $34.87













FATE Short Interest - Frequently Asked Questions

What is Fate Therapeutics' current short interest?

Short interest is the volume of Fate Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 21,100,000 shares of FATE short. 23.31% of Fate Therapeutics' shares are currently sold short. Learn More on Fate Therapeutics' current short interest.

What is a good short interest ratio for Fate Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FATE shares currently have a short interest ratio of 13.0. Learn More on Fate Therapeutics's short interest ratio.

Which institutional investors are shorting Fate Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fate Therapeutics: Concourse Financial Group Securities Inc., Group One Trading L.P., Walleye Trading LLC, Walleye Trading LLC, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Fate Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 23.31% of Fate Therapeutics' floating shares are currently sold short.

Is Fate Therapeutics' short interest increasing or decreasing?

Fate Therapeutics saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 21,100,000 shares, a drop of 0.6% from the previous total of 21,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Fate Therapeutics' float size?

Fate Therapeutics currently has issued a total of 97,000,000 shares. Some of Fate Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fate Therapeutics currently has a public float of 90,510,000 shares.

How does Fate Therapeutics' short interest compare to its competitors?

23.31% of Fate Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Fate Therapeutics: Novavax, Inc. (20.90%), Twist Bioscience Co. (10.79%), Abcam plc (0.38%), BioCryst Pharmaceuticals, Inc. (15.99%), Immunocore Holdings plc (2.80%), Allogene Therapeutics, Inc. (28.60%), Vir Biotechnology, Inc. (9.80%), Relay Therapeutics, Inc. (25.60%), Krystal Biotech, Inc. (6.97%), and Iovance Biotherapeutics, Inc. (13.96%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: KLA Co. ($2.87 billion), Lucid Group, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.08 billion), Coinbase Global, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.85 billion), Chesapeake Energy Co. ($1.81 billion), Rivian Automotive, Inc. ($1.64 billion), Lumen Technologies, Inc. ($1.61 billion), Plug Power Inc. ($1.50 billion), and Generac Holdings Inc. ($1.49 billion). View all of the most shorted stocks.

What does it mean to sell short Fate Therapeutics stock?

Short selling FATE is an investing strategy that aims to generate trading profit from Fate Therapeutics as its price is falling. FATE shares are trading up $1.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fate Therapeutics?

A short squeeze for Fate Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FATE, which in turn drives the price of the stock up even further.

How often is Fate Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FATE, twice per month. The most recent reporting period available is July, 31 2022.



This page (NASDAQ:FATE) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.